On ECHEMI
Home > Drugs > Mitiglinide Calcium Capsules

Mitiglinide Calcium Capsules

Function and Efficacy

Mitiglinide binds to the sulfonylurea receptors on the pancreatic β-cell membrane, inhibiting the ATP-sensitive K channels on the pancreatic β-cell membrane, causing cell depolarization and increased intracellular Ca2 concentration, thereby promoting insulin secretion and lowering blood sugar.

Ingredients

Mitiglinide calcium.

Name Description Content CAS NO. Manufacturer
Mitiglinide calcium dihydrateIngredients

Mitiglinide binds to the sulfonylurea receptors on the pancreatic β-cell membrane, inhibiting the ATP-sensitive K channels on the pancreatic β-cell membrane, causing cell depolarization and increased intracellular Ca2 concentration, thereby promoting insulin secretion and lowering blood sugar.

More
207844-01-7 8

Appearance

Capsules.

Indication

No data yet

Usage and Dosage

Take orally within 5 minutes before meals. Usually 10 mg per time for adults, 3 times a day. The dosage can be adjusted according to the patient's therapeutic effect.

Adverse Reactions

According to foreign literature reports: Among the total 1142 cases in clinical trials, 245 cases (21.5%) were reported to have adverse reactions. The main symptoms were hypoglycemia (5.8%), and others included abdominal distension (1.7%), constipation (1.2%), diarrhea (1.1%) and other digestive tract symptoms, as well as headache (1.0%). In addition, abnormal clinical examination values occurred in 245 cases (21.5%) among the total 1137 cases. Mainly including increased pyruvate (6.4%), increased γ-GTP (4.1%), increased lactic acid (2.9%), increased ALT (GPT) (2.8%), increased free fatty acids (2.1%), etc.

Precautions

The following patients should not use this product: 1. Patients with severe ketosis, diabetic coma or pre-coma, type 1 diabetes (because they must be infused and use insulin to quickly reduce high blood sugar, so this product is not suitable for use). 2. Patients with severe infection, perioperative period, and severe trauma (because they must use insulin to quickly control blood sugar, so this product is not suitable for use). 3. Patients with a history of allergy to the ingredients of this product. 4. Pregnant women or women who may become pregnant.

Special Population Medication

Precautions for children: Not clear yet. Precautions for pregnancy and lactation: 1. Pregnant women or women who may become pregnant are prohibited from taking this product. 2. This product can be secreted through breast milk. Lactating women should stop breastfeeding when using this product. Precautions for the elderly: Elderly patients usually have low physiological functions. They should start with a low dose (5 mg each time) according to symptoms and pay attention to monitoring blood sugar levels. Administer the drug with caution.

Drug Interactions

Caution should be exercised when using mitiglinide calcium in combination with the following drugs. Pay attention to monitoring blood sugar levels and reduce or increase the dosage if necessary.

Storage

seal.

Packaging Specification

10mg

Validity Period

24 months

Manufacturer

Yantai Zhengfang Pharmaceutical Co., Ltd.

  • Founded in:

    2006-08-23
  • Address:

    No. 16, Qinhuaihe Road, Yantai Development Zone, Yantai Area, China (Shandong) Pilot Free Trade Zone
  • Tax NO.:

    91370600791518649C
  • Registered Funds:

    2 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.